Caplin Point Laboratories Ltd

caplinpoint.net

Caplin Point is a fast-growing, fully integrated pharmaceutical company with a dominant presence in Latin America, Francophone Africa, and a growing presence in the regulated markets such as the USA and EU. The company was established in 1990 to manufacture a range of ointments, creams, and other external applications. The company was listed in 1994 following its Initial Public Offering (IPO), which was oversubscribed 117 times. The proceeds of which were deployed in setting up a manufacturing facility at Pondicherry. Thereafter, the company expanded its product range and increased its production capacity. The company focused on the emerging markets of Latin America, the Caribbean, Francophone and Southern Africa, and is today one of the leading suppliers of pharmaceuticals in these regions, with over 4000 product licenses across the globe. The company thrives on a unique business model of owning distribution networks, catering predominantly to the bottom of the pyramid, in the areas of its presence.